BIOLINE RX LIMITED
BLRX·09071M304·US·ADR·Healthcare - Biotechnology-13D/G
BLRX (BIOLINE RX LIMITED) is held by 11 institutional investors as of Q1 2026. Largest holders: XTX Topco Ltd ($25,274), RHUMBLINE ADVISERS ($5,432), BNP PARIBAS FINANCIAL MARKETS ($4,140). Net institutional sentiment: Bearish.
11
Holders
Avg rating(4 Elite)
$44,649
Total Value
29% (13)
Fund Consensus
2 buying - 5 selling
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer